tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP
Holding GTBP?
Track your performance easily

GT Biopharma (GTBP) Ownership - Who Owns GT Biopharma?

218 Followers

GT Biopharma (GTBP) Ownership Overview

1.05%<0.01%0.47%98.48%
<0.01% Other Institutional Investors
0.47% ETFs
98.48% Public Companies and
Individual Investors
The ownership structure of GT Biopharma (GTBP) stock is a mix of institutional, retail, and individual investors. Approximately 1.52% of the company’s stock is owned by Institutional Investors, and 98.48% is owned by Public Companies and Individual Investors.
The ownership structure of GT Biopharma (GTBP) stock is a mix of institutional, retail, and individual investors. Approximately 0.47% of the company’s stock is owned by Institutional Investors, 1.05% is owned by Insiders, and 98.48% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
13,044Institution0.58%22,762
10,504Institution0.47%18,329
10,504Institution0.47%18,329

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
13,044Institution0.58%22,762
10,504Institution0.47%18,329

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
10,504Institution0.47%30,882

FAQ

Who Owns GT Biopharma (GTBP)?
Currently, no data Available
What percentage of GT Biopharma (GTBP) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of GT Biopharma (GTBP) stock is held by institutional investors.
    What percentage of GT Biopharma (GTBP) stock is held by retail investors?
    According to the latest TipRanks data, approximately 98.48% of GT Biopharma (GTBP) stock is held by retail investors.
      Who owns the most shares of GT Biopharma (GTBP)?
      Fidelity Concord Street Trust owns the most shares of GT Biopharma (GTBP).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis